A new wave of plaintiffs have joined the opioid-epidemic litigation with five class actions filed on Tuesday: consumers who claim they’re seeing skyrocketing health insurance costs as a result of the crisis.
The suits, filed in New York and four other states states, were brought by individual persons against opioid manufacturers and distributors, and are among the few class actions filed against drug makers and marketers. The vast majority of cases have been separate actions brought by government entities like cities and counties.
